323 related articles for article (PubMed ID: 27845235)
1. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
[TBL] [Abstract][Full Text] [Related]
2. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
[TBL] [Abstract][Full Text] [Related]
3. [Clinical phenotype and immunological features of a patient with A20 haploinsufficiency].
Huang YY; He TY; Xia Y; Luo Y; Weng RH; Luo SL; Yang J; Zhao XD
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):218-222. PubMed ID: 32135594
[No Abstract] [Full Text] [Related]
4. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
[TBL] [Abstract][Full Text] [Related]
5. A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report.
Chen Y; Huang H; He Y; Chen M; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():1414. PubMed ID: 32719680
[No Abstract] [Full Text] [Related]
6. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
8. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
9. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
[TBL] [Abstract][Full Text] [Related]
10. Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20.
Chen Y; Ye Z; Chen L; Qin T; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():574992. PubMed ID: 33101300
[No Abstract] [Full Text] [Related]
11. Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.
Dong X; Liu L; Wang Y; Yang X; Wang W; Lin L; Sun B; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
J Clin Immunol; 2019 Feb; 39(2):188-194. PubMed ID: 30810840
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of novel A20 variants in patients with atypical inflammatory diseases.
Kadowaki S; Hashimoto K; Nishimura T; Kashimada K; Kadowaki T; Kawamoto N; Imai K; Okada S; Kanegane H; Ohnishi H
Arthritis Res Ther; 2021 Feb; 23(1):52. PubMed ID: 33549127
[TBL] [Abstract][Full Text] [Related]
13. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Mutation in
Rossi MN; Federici S; Uva A; Passarelli C; Celani C; Caiello I; Matteo V; Petrocchi S; Mortari EP; De Benedetti F; Prencipe G; Insalaco A
Front Immunol; 2022; 13():804401. PubMed ID: 35154120
[TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's disease.
Tsuchida N; Kirino Y; Soejima Y; Onodera M; Arai K; Tamura E; Ishikawa T; Kawai T; Uchiyama T; Nomura S; Kobayashi D; Taguri M; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Nakajima H; Miyatake S; Matsumoto N
Arthritis Res Ther; 2019 Jun; 21(1):137. PubMed ID: 31164164
[TBL] [Abstract][Full Text] [Related]
17. TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases.
Aslani N; Asnaashari K; Parvaneh N; Shahrooei M; Sotoudeh-Anvari M; Shahram F; Ziaee V
Pediatr Rheumatol Online J; 2022 Sep; 20(1):78. PubMed ID: 36064566
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of A20 caused by a novel pathogenic missense variant of TNFAIP3 and successfully treated with anti-TNF and immunosuppressive therapies.
Lina S; Ya'nan H; Ying Y; Fengfan W; Xin H; Xiaoxia R; Ying F
Cell Immunol; 2023; 391-392():104753. PubMed ID: 37535999
[TBL] [Abstract][Full Text] [Related]
19. Case Report: A novel mutation in
Cao C; Fu X; Wang X
Front Endocrinol (Lausanne); 2023; 14():1131437. PubMed ID: 37324276
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
